Scarica l'app Stockscreener
113.48
0.38%
-0.43
Dopo l'orario di chiusura:
113.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$113.91
Aprire:
$113.62
Volume 24 ore:
6.17M
Relative Volume:
1.34
Capitalizzazione di mercato:
$196.83B
Reddito:
$41.22B
Utile/perdita netta:
$5.77B
Rapporto P/E:
34.49
EPS:
3.29
Flusso di cassa netto:
$6.49B
1 W Prestazione:
+1.04%
1M Prestazione:
+0.17%
6M Prestazione:
+8.41%
1 anno Prestazione:
-0.39%
Intervallo 1D:
$113.39
$114.79
Intervallo di 1 settimana:
$110.86
$114.79
Portata 52W:
$99.71
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move? - Nasdaq
MassMutual Private Wealth & Trust FSB Decreases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Annex Advisory Services LLC Purchases 3,177 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Arkadios Wealth Advisors Sells 3,749 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Carotid Stent Market Overall Study Report 2025-2032 | Abbott Laboratories, B. Braun SE, Biotronik SE & Co KG - openPR
Abbott Laboratories (NYSE:ABT) Shares Purchased by Financial & Tax Architects LLC - MarketBeat
HB Wealth Management LLC Purchases 14,259 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Verity & Verity LLC Increases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lummis Asset Management LP Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Integrated Investment Consultants LLC Acquires 11,475 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Folger Nolan Fleming Douglas Capital Management Inc. Sells 3,851 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Lifted by Brooklyn Investment Group - MarketBeat
Aaron Wealth Advisors LLC Has $1.47 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Looking to the Future: Why Abbott Laboratories is a Must-Watch Stock - Jomfruland.net
Jim Cramer on Abbott Laboratories (ABT): ‘I Think Abbott Will Win These Baby Formula Cases’ - Insider Monkey
5,660 Shares in Abbott Laboratories (NYSE:ABT) Bought by Sax Wealth Advisors LLC - MarketBeat
Merit Financial Group LLC Buys 7,316 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.45 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Trust Co. of Vermont Sells 9,600 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Biomarker Industry Market is Booming Worldwide | Abbott Laboratories, Roche Diagnostics - openPR
Relyea Zuckerberg Hanson LLC Purchases 14,960 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Householder Group Estate & Retirement Specialist LLC - MarketBeat
Avanza Fonder AB Invests $20.64 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
Tompkins Financial Corp Buys 2,410 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Chemistry Wealth Management LLC Makes New $267,000 Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Declining Stock and Decent Financials: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance
Empirical Asset Management LLC Has $5.41 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Inspirion Wealth Advisors LLC - MarketBeat
Ritholtz Wealth Management Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Carnegie Investment Counsel Increases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Marker Testing Market May See a Big Move | Abbott Laboratories, Thermo Fisher Scientific - openPR
Abbott Laboratories (ABT) to Release Earnings on Wednesday - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott pushes toddler milks that can cause health issues: lawsuit - New York Post
Abbott Laboratories (NYSE:ABT) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
StrongBox Wealth LLC Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Brady Family Wealth LLC Sells 2,687 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Baby formula maker sued for deceptively marketing sugar-filled milk - WWJ
St. Louis Financial Planners Asset Management LLC Invests $1.77 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
3,855 Shares in Abbott Laboratories (NYSE:ABT) Acquired by USA Financial Formulas - MarketBeat
Abbott Labs sued for allegedly misleading parents in toddler milk products - KHOU.com
Sawyer & Company Inc Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Websterrogers Financial Advisors LLC Takes $259,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Sendero Wealth Management LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Park Avenue Securities LLC - MarketBeat
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, - EIN News
Abbott's Toddler Nutrition Drinks Aren't Healthy, Parents Claim - Law360
Abbott closes Cardiomems coverage saga with Medicare win - BioWorld Online
Abbott accused of deceiving parents with potentially harmful formula for toddlers - CBS News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):